ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
janssen
['cilta-cel', 'mmsm']
aa11: rr in cilta-cel vs soc 85% and 67%, cr 73% vs 22% while those who received cilta-cel rr was 99.4% while cr 86% #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter